The Effects of Implementing a Mobile Health–Technology Supported Pathway on Atrial Fibrillation–Related Adverse Events Among Patients With Multimorbidity: The mAFA-II Randomized Clinical Trial

IMPORTANCE: The Mobile Health Technology for Improved Screening and Optimized Integrated Care in Atrial Fibrillation (mAFA-II) trial is a prospective cluster randomized trial that found a significant reduction in the composite clinical outcome of stroke or thromboembolism, all-cause death, and rehos...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Yuan, Guo, Yutao, Lip, Gregory Y. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693229/
https://www.ncbi.nlm.nih.gov/pubmed/34932104
http://dx.doi.org/10.1001/jamanetworkopen.2021.40071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693229/
https://www.ncbi.nlm.nih.gov/pubmed/34932104
http://dx.doi.org/10.1001/jamanetworkopen.2021.40071

Ejemplares similares